Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cryo-Cell Intl Inc (CCEL)

Cryo-Cell Intl Inc (CCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cryo-Cell Intl Inc 700 Brooker Creek Blvd. Suite 1800 Oldsmar FL 34677 USA

www.cryo-cell.com Employees: 86 P: 813-749-2100

Sector:

Medical

Description:

CRYO-CELL International is engaged in cryogenic cellular storage and the design and developmentof cellular storage devices. They currently focus on the processing and preservation of umbilical cord blood stem cells for autologous/sibling use. They have pioneered several technologies that allow for the processing and storage of specimens in a cryogenic environment, and presently, their mission of affordability for U-Cord blood preservation remains in effect.

Key Statistics

Overview:

Market Capitalization, $K 32,140
Enterprise Value, $K 43,410
Shares Outstanding, K 8,055
Annual Sales, $ 31,990 K
Annual Net Income, $ 400 K
Last Quarter Sales, $ 7,830 K
Last Quarter Net Income, $ 750 K
EBIT, $ 5,090 K
EBITDA, $ 6,130 K
60-Month Beta 0.55
% of Insider Shareholders 38.59%
% of Institutional Shareholders 10.44%
Float, K 4,947
% Float 61.41%
Short Volume Ratio 0.84

Growth:

1-Year Return -54.97%
3-Year Return -9.11%
5-Year Return -46.80%
5-Year Revenue Growth 0.53%
5-Year Earnings Growth -82.76%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.09 on 10/15/25
Next Earnings Date 10/21/25
Earnings Per Share ttm -0.07
EPS Growth vs. Prev Qtr 125.00%
EPS Growth vs. Prev Year -30.77%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Most Recent Dividend 0.150 on 05/21/25
Next Ex-Dividends Date 05/21/25
Dividend Payable Date 05/30/25
Dividend Payout Ratio 1,117.02%

CCEL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -0.74%
Profit Margin % 1.25%
Debt/Equity -0.77
Price/Sales 1.02
Price/Cash Flow 22.04
Price/Book N/A
Book Value/Share -1.84
Interest Coverage 2.51

CCEL Dividends

Date Value
05/21/25 $0.1500
02/14/25 $0.2500
11/15/24 $0.2500
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar